2018-10-12 00:15:00| Fool.com Headlines
Investors were not impressed with the biotech's R&D day.
2018-10-11 23:04:00| Fool.com Headlines
A recently announced debt financing won't dilute shareholders, but it still has Wall Street worried.
2018-10-11 23:01:00| Fool.com Headlines
The threat of government regulation and higher expenses left investors in the social media platform reeling last month. Here's what you need to know.
2018-10-11 21:02:00| Fool.com Headlines
Enthusiasm for the biopharma is wearing off despite its announcement of an important commercial milestone.
2018-10-11 18:16:00| Fool.com Headlines
Two moves that may help SolarEdge Technologies long term didn't help the company's stock short term.